Search results for

Japanese businesses are increasingly turning to litigation to resolve their IP disputes. Lloyd Parker, Andrew Cobden and Yukihiro Otani spoke to Japanese managers to find out what lies behind the trend

In order to promote pharmaceutical research within the European Community and to keep the pharmaceutical industry from relocating to countries which offer better protection, EC Regulation Number 1768/92 for supplementary protection certificates (SPCs) was created. SPCs in the Netherlands are also governed by Regulation Number 1768/92. This is a clear and simple regulation which was meant to extend the life of a patent as far as it covered a medicinal product which had received regulatory approval and which should have led to harmonized SPC legislation in the European Community.

There are various ways to pursue infringers and seek restitution. Agustín Velázquez, Gabriel Pardo, Alberto Huerta Bleck and Alvaro Huerta of Mijares Angoitia Cortes y Fuentes SC outline what is available to rights owners

Claiming the date of commencement of use of trade marks in Mexico raises some tricky issues. Jaime Delgado and Arturo D Reyes of Goodrich Riquelme & Asociados explain

A monthly column devoted to the curiosities and controversies of the IP world

Intellectual property valuation has novelty value among IP professionals not used to the mainstream importance of intangible assets. But as Gustavo A Alcocer and Carlos Woodworth of Olivares & Cia argue, valuing your IP is essential if you plan to use your assets in a productive fashion

In E-Toyo Global Stationery v Toyo Ink [2005], the first respondent was the registered proprietor of the trade mark Toyo in Class 16 and had been the registered proprietor since 1979. In 2002, the first respondent entered into a registered user agreement with the second respondent to use the Toyo mark. In 2004, a third party (not a party to this action) became a registered user and gained a licence to use the Toyo mark by way of a novation cum registered user agreement with the first respondent. The applicant alleged that as a result of the 2002 registered user agreement, an act of so-called "trafficking" had been committed.

The Singapore Patents Act was amended on July 1 2004. The amendments have brought about various changes to the search and examination options available to applicants using the PCT route. The options available for applications with filing dates both before and after July 1 2004 are outlined below.

By their nature, life science companies are among the more IP-dependent businesses in the corporate world. Any transactions, therefore, will require a more thorough due diligence than is the norm. Paul M Booth and Leslie Mooi outline 10 things you should know about such a company before deciding to invest in, or acquire, it

According to Regulation 1768/92/EEC supplementary protection certificates (SPCs) can be granted for novel medicines. They are intended to compensate for the reduced effective lifetime of patents covering such medicines.